Well hello, Alto.
Alto is the world’s first digital SPR system that delivers high-quality, reproducible binding kinetics without the fluidic complexity, maintenance burden, or large sample requirements of traditional SPR.
The Revolution is now.
Meet Revo – the newest digital SPR platform designed not just to improve the way scientists run kinetics, but to fundamentally change who can run them. No 100 µL sample sacrifices. No steep learning curve. Scale from 4 to 8-channel as our science grows. This isn’t an incremental improvement. This is SPR reimagined for the scientists who refuse to compromise.
Meet Revo. SPR reimagined for real-world biologics.
Revo combines the power of high-end SPR with the accessibility of BLI, all without fluidic maintenance, large sample requirements, or traditional instrument complexity. This isn’t an incremental improvement. This is SPR reimagined for the scientists who refuse to compromise.
Why Nicoya?
Fewer barriers,
better data
Automated workflows and low sample consumption reduce setup time and experimental risk.
Data that pushes your science forward
Reproducible, publication-quality results across binding, structure, stability, and kinetics.
A portfolio that
works together
From DSF and SPR to CD and ultra-fast kinetics, our combined Nicoya and Applied Photophysics platforms support confident decisions across the full workflow.
“We’re confident that the Alto is replicating data we established almost 30 years ago. It’s remarkable to see the same binding characteristics now, using a modern platform.”
Dr. Chris Heger,
Professor, Pharmacology & Neuroscience
University of North Texas, Health Science Center
“The OpenSPR data was critical for getting our research published because it allowed us to experimentally quantify protein-protein interaction, which would otherwise not be possible with pull-down assays. OpenSPR provided us with a cost-effective method to obtain large amounts of accurate data using small amounts of sample!”
Maryam Moazami-Goudarzi,
University of Toronto Mississauga
“The Chirascan system at the Manchester Institute of Biotechnology is used to advance biological, biochemical, and medical research. Our scientists use CD to gain an understanding of how mutations, buffer or stress conditions affect protein structure and to confirm the stereostructure of small molecules. The system is routinely used by more than 25 scientists and is typically in use 90% of the time. The system is intuitive making user training straightforward. Users return to the Chirascan because it is highly reproducible, has excellent signal:noise and delivers results quickly.”
Dr. Derren Heyes,
University of Manchester
“After one training session, I ran my experiments immediately using the LIP chips and looked at protein binding to different lipid mixtures. The data is beautiful and the instrument is by far one of the easiest and user-friendly that I have ever used!”
Dr. Tonya N. Zeczycki,
Assistant Professor of Biochemistry & Molecular Biology
East Carolina University
News
Nicoya Lifesciences Announces Launch of Multichannel Benchtop SPR Instrument, Aimed to Deliver Publication-Quality, Real-time Kinetic Data to Small and Midsize Research Labs
Canada-UK Collaboration Developing AI-powered Bioreactors to Revolutionize Biopharmaceutical Manufacturing
Nicoya Acquires Applied Photophysics, Expanding Biologics Characterization Capabilities for Faster Time-to-Clinic and Reduced Late-Stage Failures
